Products

The monthly dapivirine vaginal film is being developed by the Rohan Pharmaceutics laboratory at the University of Pittsburgh School of Pharmacy and Magee-Womens Research Institute under the VALUE (Vaginal film as A Low-cost, User-administered, and Extended-release product) project as a female-controlled product providing monthly protection against HIV infection. Because the film is designed to completely dissolve, there would be nothing to remove.

Similar to the dapivirine-only film, the dual-purpose vaginal film is being designed as a discreet method for one-month protection against both HIV and unplanned pregnancy.

The non-antiretroviral, non-hormonal intravaginal ring developed by the Oak Crest Institute of Science is a method to protect women against both HIV and unplanned pregnancy for one month at a time. The ring, which is made of a soft and flexible silicone, is designed to be inserted and removed by women themselves.

The tenofovir alafenamide/elvitegravir (TAF/EVG) fast dissolving insert is being developed by CONRAD, a non-profit research organization affiliated with Eastern Virginia Medical School, as an on-demand method in HIV prevention product that women would insert into their vagina around the time of sex.